Company · CIK 0001668243 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
UroGen Pharma Ltd. · URGN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 SForm 4 → | Sep 9, 2:37 pm EDT | Mark SchoenbergChief Medical Officer | 871 | $42.92 | $37,383 | 59,882 | −1.43% | |
| Sep 8, 2026 SForm 4 → | Sep 9, 2:35 pm EDT | Jason Drew SmithGeneral Counsel | 1,519 | $42.54 | $64,618 | 53,141 | −2.78% | |
| Sep 7, 2026 MForm 4 → | Sep 9, 2:37 pm EDT | Mark SchoenbergChief Medical Officer | 1,667 | — | — | 60,753 | — | |
| Sep 7, 2026 MForm 4 → | Sep 9, 2:35 pm EDT | Jason Drew SmithGeneral Counsel | 3,334 | — | — | 54,660 | — | |
| Aug 26, 2026 MForm 4 → | Aug 28, 4:01 pm EDT | James A. Robinson Jr.Director | 2,000 | — | — | 8,000 | — | |
| Aug 20, 2026 SForm 4 → | Aug 24, 5:03 pm EDT | Mark SchoenbergChief Medical Officer | 60,677 | $47.05 | $2,854,853 | 59,086 | −50.7% | |
| Jul 9, 2026 SForm 4 → | Jul 10, 2:17 pm EDT | Mark SchoenbergChief Medical Officer | 10,000 | $40.00 | $400,000 | 119,763 | −7.71% | 10b5-1 |
| Jun 22, 2026 SForm 4 → | Jun 24, 10:22 am EDT | Mark SchoenbergChief Medical Officer | 10,000 | $35.01 | $350,100 | 129,763 | −7.15% | 10b5-1 |
| Jun 8, 2026 SForm 4 → | Jun 9, 1:59 pm EDT | Mark SchoenbergChief Medical Officer | 5,222 | $27.30 | $142,561 | 139,763 | −3.60% | |
| Jun 8, 2026 MForm 4 → | Jun 9, 1:59 pm EDT | Mark SchoenbergChief Medical Officer | 10,000 | — | — | 144,985 | — | |
| Mar 6, 2019 SForm 4 → | Mar 7, 9:46 pm EST | Mark SchoenbergChief Medical Officer | 1,991 | $37.30 | $74,264 | 4,338 | −31.5% | plan? |
| Mar 4, 2019 MForm 4 → | Mar 7, 9:46 pm EST | Mark SchoenbergChief Medical Officer | 1,042 | — | — | 6,329 | — | plan? late |
| Feb 14, 2019 SForm 4 → | Mar 7, 9:44 pm EST | Stephen MullennixChief Operating Officer | 2,804 | $37.30 | $104,589 | 4,230 | −39.9% | plan? late |
| Feb 14, 2019 MForm 4 → | Mar 7, 9:44 pm EST | Stephen MullennixChief Operating Officer | 7,034 | — | — | 7,034 | — | plan? late |
| Nov 27, 2017 SForm 4 → | Nov 29, 5:07 pm EST | ProQuest Investments IV, L.P. +310% Owner | 209,298 | $40.60 | $8,497,871 | 1,242,031 | −14.4% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2026 MForm 4 → | Sep 9, 2:37 pm EDT | Mark SchoenbergChief Medical Officer | 1,667 | — | — | 0 | — | |
| Sep 7, 2026 MForm 4 → | Sep 9, 2:35 pm EDT | Jason Drew SmithGeneral Counsel | 3,334 | — | — | 0 | — | |
| Aug 26, 2026 MForm 4 → | Aug 28, 4:01 pm EDT | James A. Robinson Jr.Director | 2,000 | — | — | 0 | — | |
| Jun 22, 2026 AForm 4 → | Jun 24, 10:03 am EDT | Daniel George WildmanDirector | 18,000 | — | — | 8,000 | — | |
| Jun 22, 2026 AForm 4 → | Jun 24, 10:02 am EDT | James A. Robinson Jr.Director | 18,000 | — | — | 8,000 | — | |
| Jun 22, 2026 AForm 4 → | Jun 24, 10:01 am EDT | Stuart HoldenDirector | 20,000 | — | — | 20,000 | — | |
| Jun 22, 2026 AForm 4 → | Jun 24, 10:00 am EDT | Cynthia M ButittaDirector | 18,000 | — | — | 8,000 | — | |
| Jun 22, 2026 AForm 4 → | Jun 24, 9:58 am EDT | Leana WenDirector | 18,000 | — | — | 8,000 | — | |
| Jun 22, 2026 AForm 4 → | Jun 24, 9:57 am EDT | Arie BelldegrunDirector | 20,000 | — | — | 20,000 | — | |
| Jun 8, 2026 MForm 4 → | Jun 9, 1:59 pm EDT | Mark SchoenbergChief Medical Officer | 10,000 | — | — | 0 | — | |
| Mar 4, 2019 MForm 4 → | Mar 7, 9:46 pm EST | Mark SchoenbergChief Medical Officer | 1,042 | — | — | 7,292 | — | late |
| Feb 14, 2019 MForm 4 → | Mar 7, 9:44 pm EST | Stephen MullennixChief Operating Officer | 7,034 | — | — | 14,073 | — | late |
| Jan 26, 2019 AForm 4 → | Jan 29, 5:26 pm EST | Stephen MullennixChief Operating Officer | 20,000 | — | — | 5,000 | — | |
| Jan 26, 2019 AForm 4 → | Jan 29, 5:25 pm EST | Peter P. PfreundschuhChief Financial Officer | 20,000 | — | — | 5,000 | — | |
| Jan 26, 2019 AForm 4 → | Jan 29, 5:24 pm EST | Mark SchoenbergChief Medical Officer | 10,000 | — | — | 2,500 | — | |
| Jan 3, 2018 AForm 4 → | Jan 9, 2019, 8:25 pm EST | Elizabeth A. BarrettChief Executive Officer | 594,497 | — | — | 317,065 | — | late |